Why it matters

Neurology research is centred on finding appropriate treatments for people living with disorders of the brain, spinal cord, and nervous system. These can include epilepsy, Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, and dementia with Lewy bodies.

Globally, more than 55 million people live with dementia* and more than 10 million people live with Parkinson’s disease**. And the overall burden of neurological disorders is incredibly high. Worldwide, they are the leading cause of disability and the second leading cause of death***. The debilitating nature of many neurological disorders means their impact spreads throughout the patient’s network, with caregivers required often on an extensive basis. This ensures neurological disorders have a significant medical, societal, and economic impact.

What we do

In neurology research around the world, we work closely with CROs and medical researchers to ensure all project management targets are met. Our range of infusion pumps is a critical part of our offering to CROs overseeing neurology clinical trials research. We are also relied upon to supply fully calibrated refrigerators, freezers, thermometers, temperature dataloggers, and scales. Extensive international warehousing and distribution partnerships guarantee that all our equipment reaches its intended site on time and on budget. 

Featured case study

Featured blog

Equipment for neurology trials

Got a question?

Got a question?

Why partner with us?

Our 30+ years of experience with product knowledge, sourcing quality, regulatory intelligence and logistical knowhow makes us experts in what we do.

We take care of details – providing reassurance and saving you time and money from end-to-end of your clinical trial.

More about us

More therapeutic areas

See all therapeutic areas


* https://dementiastatistics.org/statistics/global-prevalence/

** https://www.parkinson.org/understanding-parkinsons/statistics

*** https://impact.economist.com/perspectives/sites/default/files/download/the_value_of_action-_mitigating_the_global_impact_of_neurological_disorders_infographic1_sep_2022.pdf